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Abstract
 This case concerns a 73 year-old woman, that suffered from symptomatic aortic abdominal aneurysm. Due 
to the complex anatomy of the aneurysm she was treated with nellix endovascular aneurysm seal device. The 
implantation was successful, and the completion angiography showed no endoleak. On the 9th day after the 
procedure, the patient presented severe abdominal pain with peritoneal symptoms, significant anemia and 
hypovolemic shock. The patient was subject to emergency laparotomy. The aortic rupture was identified. The 
Nellix device was removed and replaced with bifurcated silver-covered PTFE graft.
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Introduction
In recent years numerous new technologies were 
introduced in aortic abdominal aneurysm (AAA) treat-
ment. One of them is the nellix device for endovascular 
aneurysm seal (EVAS). According to the manufacturer 
the system „is the next generation in AAA therapy, 
intended to treat more anatomies than currently ap-
proved endovascular stent graft devices”. In an initial 
clinical trial involving 34 patients, 100% implant success 
was observed. After two year follow-up, no aneurysm 
rupture, conversion to open surgery or stent graft 
migration was observed [1].
Case presentation
73 year-old woman has been admitted to the hos-
pital due to severe abdominal pain, with a history of 
AAA diagnosed few months prior to the event. The 
comorbidities were hypertension and hypothyroidism. 
The CT angiography revealed a rapid diameter growth 
from 46mm to 53mm in 3 months, an intraluminal clot 
and a minor dissection on the atherosclerotic plaque. 
The anatomy of the aneurysm was complex. Each 
of the kidneys was supplied by two renal arteries. In 
both cases the lower renal arteries were dominant. 
The left lower renal artery originated from the aneu-
rysm (Fig. 1). The right lower renal artery originated 
just a few millimeters above the aneurysm (Fig. 2), the 
aortic diameter at that level was 26 mm. In addition, 
the aorta above was “Z” shape angulated (Fig. 1). Both 
iliac arteries were patent. The left iliac artery was over 
90* angulated (Fig. 1).
Considering the potential benefits of Nellix EVAS 
and its broad applicability, it was the only endovascular 
option for the patient to save at least one kidney (by 
sealing only 1 of 4 renal arteries). Other devices would 
not be suitable due to a very short and angulated neck, 
although we can hardly identify the neck at all in this case.
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Two 10 mm × 160 mm Nellix stents were posi-
tioned from just below the lower right renal artery into 
the common iliac arteries. The attached endobags were 
prefilled with saline and then filled with liquid polymer 
under pressure monitoring.
The procedure was successful and the completion 
angiography showed EVAS with no endoleak (Fig. 3). 
The right lower renal artery was not sealed and the 
right kidney circulation was normal. The left lower renal 
artery was closed, as intended. Circulation in the left 
kidney was impaired.
In the first few days after the procedure the patient 
presented increasing abdominal pain. On the 4th day the 
ultrasound revealed left retroperitoneal hematoma, 
blood test showed minor anemia. The patient was re-
operated. The on call surgeon suspected the bleeding 
originating from left femoral artery communicating 
with the retroperitoneal space under the inguinal 
ligament. Revision of left femoral artery revealed no 
bleeding, the retroperitoneal space was opened, and 
the hematoma evacuated. Minor bleeding from the left 
common iliac artery was identified, located just at the 
end of the left stent, where the artery angulated. No 
aortic rupture was identified. For another few days 
the patient remained asymptomatic and seemed to be 
recovering well.
On the 9th day, the patient presented severe ab-
dominal pain with peritoneal symptoms, significant 
anemia and hypovolemic shock. The patient was sub-
ject to emergency laparotomy. A large retroperitoneal 
hematoma was identified. After removing it, a large 
rupture on the anterolateral aortic wall with severe 
bleeding was found. The rupture was approximately 
Figure 1. Left renal arteries, left iliac artery Figure 2. Right renal arteries
Figure 3. Completion angiography
Figure 4. Draft of the rupture
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procedure. We cannot tell if the rupture was the result 
of an early endoleak or the aortic wall was damaged 
by the system itself during the procedure. We do not 
know exactly how the polymer filled endobag interacts 
with the aortic wall and what happens to the calcified 
lesions. Can they damage the aortic wall? We do not 
know what happens with the intraluminal clot. Can the 
pressure monitor fail during the procedure? Biophysical 
mechanics in atherosclerotic and dilated aortic wall is 
very complex. Expanding EVAS system inside aortic 
lumen must somehow change the forces that interact 
the aortic wall. As the goal of every endovascular AAA 
procedure is to reduce the pressure on aneurysm wall, 
during EVAS operation there may be some temporary 
increase of the tension during endobag inflation. The 
pressure monitor provided with Nellix is installed to the 
catheter on the external part of the system, which is 
quite far away from the sack itself. Considering elasticity 
of the catheter, the measurements may be inaccurate. 
Conclusions
Endovascular treatment of AAA will always be 
a complex process, apart from the procedure itself, 
the most important step is precise qualification and 
optimal device selection. Nellix is the most contrasting 
system, as it is the only one that seals the entire aneu-
rysm sack. That is why, EVAS still seems a promising 
method for adverse anatomy aneurysms, but we must 
consider a possibility of complications, when choosing 
best treatment option for the patient. More study on 
mechanical interaction of the system with aortic wall 
seems necessary.
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4 cm long and up to 2 cm wide (Fig. 4), it was mostly 
covered with the polymer-filled endobag. The bleed-
ing originated from the proximal part of the rupture. 
The graft was removed and replaced with bifurcated 
silver-covered PTFE graft.
In the examination of the removed Nellix none of 
the elements appeared to be damaged. Endobags were 
not torn, the polymer was firm (Fig. 5).
On the following days the patient was managed in 
ICU, due to Multiple Organ Dysfunction Syndrome 
(renal failure, intestinal necrosis, heart failure). The 
patient was subject to 3 subsequent laparotomies due to 
intestinal ischemia and necrosis. Eventually the patient 
died on the 29th day after the surgery.
Discussion
Nellix EVAS is not a 100% successful AAA repair 
method. The EVAS FORWARD study revealed freedom 
from reintervention on the 12th month was 98% when 
used inside the IFU (instructions for use), compared 
to 86% if outside the IFU (as in this case). The pre-
sented case brings more questions than answers. No 
endoleak was identified in completion angiography. 
This suggests that the implant migrated soon after the 
Figure 5. Nellix stents after explantation
